UNH Filing
4Filing Date: Jul 6, 2026

UNITEDHEALTH GROUP INC (UNH) · Insider Trading (Form 4) SEC Filing

Statement of Changes in Beneficial Ownership

descriptionView SEC Filing
ACC: 0000731766-26-000187open_in_new
Total Value$0
Trades1
Insiders1

Transaction Details

MONTGOMERY RICE VALERIE MD
Director·Direct
Grant · Acquire
Common Stock
Shares+220
Price$0.00
Total Value$0
Shares Owned After7.88K
Transaction DateJul 1, 2026
Footnotes ▸

Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board.

Post-Transaction Holdings

MONTGOMERY RICE VALERIE MD
SecuritySharesChange
Common Stock7.88K+220 (2.87%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-07-01 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: UNITEDHEALTH GROUP INC (UNH) CIK: 0000731766 --- Reporting Owner --- Name: MONTGOMERY RICE VALERIE MD CIK: 0001714561 Role: Director --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-07-01 | Code: A (Grant or award) Shares: +220 | Price: $0.00 Shares Owned After: 7,876 | Ownership: D (Direct) Footnotes: [F1] Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board. --- Footnotes (Complete Index) --- F1: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board. --- Signature --- /s/ Faraz A. Choudhry, Attorney-in-Fact for Valerie C. Montgomery Rice M.D. (2026-07-06)

keid AI analysis is for reference only and does not constitute investment advice.